Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

Phase 3
1(100.0%)
1Total
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06739239Recruiting

French COhoRte Extra-Vascular Implantable CardiovErter DefibrillatoR

Role: collaborator

NCT05953558Recruiting

French Cohort Evaluating the effectiveneSs of Atrioventricular Synchrony by the micRa AV

Role: collaborator

NCT05302115Unknown

S-ICD French Cohort Study (HONEST)

Role: collaborator

NCT02744495Phase 3Completed

Prophylaxis of Postoperative Nausea and Vomiting After Cardiac Surgery

Role: lead

NCT01918670Unknown

A French Multi-centric Atrial Fibrillation Catheter Ablation Survey

Role: collaborator

All 5 trials loaded